Document is current
Any future updates will be listed below
-
Authors
Si, Dongjuan
Dong, Zhihao
Xing, Gang
Yao, Longfang
Lu, Jun
Ma, Min
Yuan, Yue
Zhao, Hanqing https://orcid.org/0000-0002-1037-4829
Dong, Biqin https://orcid.org/0000-0003-2283-4498
Li, Cong https://orcid.org/0000-0001-7731-8031
Yuan, Lin https://orcid.org/0000-0002-1015-5319
Chen, Zhongwen https://orcid.org/0000-0001-5218-0152
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (22477016)
- License Information
-
More Information
Article History
Received: 14 February 2025
Accepted: 26 November 2025
First Online: 12 December 2025
Change Date: 23 February 2026
Change Type: Update
Change Details: In this article the affiliation details for Dongjuan Si, Zhihao Dong, Gang Xing, Hanqing Zhao, Cong Li and Lu Wang were incorrectly given as 'MOE Key Laboratory of Smart Drug Delivery, MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, School of Pharmacy, Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China' but should have been 'School of Pharmaceutical Sciences, MOE Key Laboratory of Smart Drug Delivery, MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, 201203, Shanghai, China'. The original article has been updated.
Competing interests
: The authors declare the following competing financial interest(s): L.W. is the inventor of the patent “Cell-permeable fluorogenic fluorophores”. Lu Wang and Dongjuan Si are inventors on a patent application (Application No. 202510760855.2, titled “Preparation and Application of a Novel Reversible Protein Labeling Tag and Sulfonamide-Based Fluorescent Probes”) filed by [CNIPA]. The remaining authors declare no competing interests.
